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1. Introduction 
It is known that 2-allyl-2-isopropylacetamide (AIA) 
induces in rodents a chemical porphyria which mimicks 
human hepatic porphyria [ 1,2] . This derrangement in 
porphyrin metabolism is characterized by a strong 
increase in the urinary excretion of the porphyrin pre- 
cursors porphobilinogen )PBG) and 5aminolevulinic 
acid (ALA), and these increases have been traced to the 
excessive induction of ALA synthetase in the rats by 
the porphyria-inducing chemical [3]. ALA synthetase 
is considered to be the main regulatory enzyme of 
porphyrin biosynthesis [4] , and its induction raises 
ALA concentration above the normal values. The 
next enzyme in the metabolic sequence - ALA 
dehydratase - transforms the excess of ALA into 
PBG with the net result of an increase in the concentra- 
tion of both porphyrin precursors, part of which is 
excreted in urine. We have reported [S] that the 
administration of pregnenolone to ALA pretreated 
rats produced a marked decrease in the amount of 
the PBG excreted in urine, and a simultaneous strong 
increase in the activity of hepatic porphobilinogen 
oxygenase activity. The latter is a novel mixed- 
function type of oxidase which we have isolated from 
plant and animal sources [6,7] , which oxidizes PBG 
to Soxo-2-hydroxy-porphobilinogen, a metabolite 
which is not transformed into porphyrins anymore. 
PBG-oxygenase isolated from either rat liver or wheat- 
germ is a cationic iron-sulfur protein possessing allo- 
steric kinetics and a multimer structure [8]. We want 
to report now that the administration of AIA not only 
induces ALA-synthetase in rats, but that it also 
induces PBG -oxygenase as well. The maximum 
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induction of the latter is coincident in time with the 
peak of PBG excretion, and has a temporal separation 
of the maximum of ALA-synthetase activity. The 
data suggest hat the sequential induction of ALA- 
synthetase and PBG-oxygenase might involve a meta- 
bolic response to the problem of excessive PBG 
formation. 
2. Materials and methods 
2-Allyl-2-isopropylacetamide (AIA) was a generous 
gift of Hoffman-La Roche Inc. (Nutley, NJ). Female 
Wistar rats (170-200 g), were fed freely on rat chow 
supplemented with wheat grain as an additional carbo- 
hydrate source. One week before starting the experi- 
ments the wheat grain was removed from the diet, and 
after the week was completed the rats were fasted 
during the remaining course of the studies. They were 
kept in metabolic cages which allowed the collection 
of the urines, and they were given water freely. Twenty- 
four hours after the fasting was started, the control 
rats were injected subcutaneously with a saline solution, 
while the treated rats were injected with AIA (250 
mg/kg) in a NaCl saline solution. Urine was collected 
24,48 and 72 h after the injections and the amount 
of excreted ALA and PBG was measured by filtering 
the pooled urines of three rats through a Dowex 
l-X4 resin column (2 X 20 cm) in its acid form. The 
column was washed with 50 ml water to elute ALA, 
and then with 50 ml 0.8 M acetic acid to elute PBG. 
The eluates were evaporated to dryness, the residues 
were dissolved in 0.5 ml water, and the amounts of 
ALA and PBG present were estimated on aliquots 
29 
Volume 84, number 1 FEBS LETTERS December 1977 
using standard methods [9]. Both ALA and PBG 
were absent in the urine of the control rats. 
2.1. Assay of hepatic enzymes 
The livers of the control and treated rats were 
excised from anesthesized animals, washed with an 
isotonic NaCl saline solution, and homogenized in a 
Potter-Elvejhem homogenizer in 8 vol. 0.25 M 
sucrose (w/v). The suspension was centrifuged at 
20 000 X g for 15 min, and the supernatant was 
centrifuged for 1 h at 105 000 X g. The microsomal 
pellet thus obtained was suspended in a saline solution 
(phosphate buffer 0.5 M, KCl 0.15 M, pH 7.4) again 
centrifuged at 105 000 X g for 30 min, and the pellet 
was suspended in phosphate buffer 0.05 M (pH 7.4) 
to protein concentration of 10-l 5 mg/ml. PBti- 
oxygenase was assayed by incubating in final vol. 
100 flul; phosphate buffer (10 /*mol, pH 7.4) PBG 
(15 nmol), sodium dithionite (100 nmol), and 50 fi 
microsomal suspension. Incubations were performed 
at 37’C for 60 min. PBG consumption was estimated 
with Ehrlich’s reagent as described [6]. ALA- 
synthetase was assayed in liver homogenates as 
described by Marver et al. [lo] . 
3. Results 
3.1. Excretion of ALA and PBG in the urines of AIA 
treated rats 
The maximum excretion of both ALA and PBG 
was observed in the urines collected between 24 h 
and 48 h after the AIA injection, though some ALA 
was already present in the 24 h urine (table 1). We 
have reported [5] that PBG excretion reaches a peak 
about 33 h after the administration of AIA. The 
Table 1 
Urinary ALA and PBG excretion in AIA treated rats 
Time after AIA injection 
(h) 
ALA excreted PBG excreted 
(nmol/rat) (nmol/rat) 
O-24 21.4 f 1.6 0 
24-48 120 + 14 146 f 11 
48-12 0 0 
ALA and PBG were determined at the indicated times as 
described in the text. Each value represents amean + 
standard error of the mean (SEM) of 20 rats 
b C 
24 72 24 ALA ALA +PBG 
Time after AIA treatment h) Trratmrnt 
Fig.1. Effect of AIA on: (a) induction of hepatic microsomal PBG-oxygenase; (b) induction of hepatic ALA-synthetase; (c) 
effect of ALA (8 mg/kg) and PBG (4 mg/kg) on the induction of PBG-oxygenase. Livers from control (clear bars) and treated 
(shaded bars) rats were obtained and used as described in the text. Results are expressed as mean f standard error of the mean 
(SEM) from at least 6 experiments, each utilizing livers from 3 control rats and 3 treated rats. 
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urines collected in the 48-72 h period were devoid 
of both metabolites. When larger rats were used 
(230-250 g), the excretion peak of PBG was reached 
during the first 24 h, and then decreased rapidly. 
3.2. Hepatic PBG-oxygenase and ALA-synthetase 
activity in AZA treated rats 
Microsomal PBG-oxygenase activity and ALA- 
synthetase activity in the excised livers of the 
control and AIA treated rats was investigated (fig.1). 
Oxygenase activity in the AIA treated rats increased 
simultaneously with ALA and PBG excretion and 
reached a maximum 48 h after the AIA treatment. 
No significant difference in PBG-oxygenase activity 
between the control and the treated rats was found 
72 h after the AIA treatment (fig.la). The higher 
values of ALA-synthetase activity were found in the 
livers excised 24 h after the AIA treatment; while in 
those excised 48 h after the treatment the values 
were almost normal (fig.lb). These last results are 
in agreement with [3], which reported a peak in 
ALA-synthetase induction in the 8--24 h period after 
AIA treatment. 
When larger rats were used, and the peak of PBG 
excretion was reached during the first 24 h period 
after the AIA treatment (see above), the peak of 
oxygenase activity was also found in the livers excised 
24 h after the treatment and was absent in the livers 
excised after 48 h. 
To examine if ALA or PBG, or both together, were 
involved in the observed PBG oxygenase induction, 
they were administered to the rats, and oxygenase 
activity was examined. ALA (4 mg/kg, 8 mg/kg and 
12 mg/kg) was subcutaneously injected into the rats 
and the excretion of these compounds in the urines 
was assayed 6, 15 and 24 h later. The 6 h urines con- 
tained 90% of all the excreted ALA and PBG formed 
at expense of the injected ALA, in a 7: 10 ratio of 
ALA:PBG. No significant increase of PBG-oxygenase 
activity over the control runs was detected in the 
ALA-treated animals (fig.lc). When ALA (8 mg/kg) 
and PBG (4 mg/kg) were administered together, 
similar results were obtained. Approx. 30% the 
injected porphyrin precursors were recovered in the 
urines. It was evident thet PBG-oxygenase activity was 
induced by the AIA treatment, and not by the por- 
phyrin precursors produced as consequence of the 
treatment. 
4. Discussion 
The above-mentioned results show that a chemical 
which increases the physiological levels of the por- 
phyrin precursors ALA and PBG, induces simul- 
taneously the formation of a microsomal mixed- 
function oxidase (PBG-oxygenase) which can partially 
dispose of the excessive PBG. The same is true for a 
hormonal imbalance such as a prolonged fasting, 
which is known [ 11 ,121 to induce the urinary excre- 
tion of ALA and PBG in humans. The transfer of the 
rats from the carbohydrate-rich diet to the carbo- 
hydrate-poor diet followed’by a relatively prolonged 
fasting, is by itself a factor in the induction of the 
hepatic microsomal PBG-oxygenase (fig.1, clear bars). 
The activity of the microsomal enzyme decreases with 
the disappearance of excess PBG, which again lends 
support to the idea of a participation of the oxygenase 
in the balance of the in vivo concentration of the 
first porphyrin precursor. 
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